Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Medifast, Inc.

Medifast, Inc. (MED) Stock Overview

Explore Medifast, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MED●NYSE
Consumer CyclicalPersonal Products & Services
$11.95
$0.33(2.84%)
U.S. Market opens in 52h 46m

Medifast, Inc. (MED)

Meyka AI Score

Z

Key Financials

Market Cap132.8M
P/E Ratio-5.11
EPS (TTM)$-1.23
ROE-0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$13.55
3 Months$11.99
1 Year Target$10.59

MED Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Medifast, Inc. (NYSE: MED) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Medifast, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MED on the NYSE shows an RSI of 58.66, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $10.59 for the NYSE listing.

Key metrics behind Medifast, Inc.'s NYSE-traded stock include a P/E ratio of -5.11 and a market capitalization of 132.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MED on the NYSE.

Price Performance (NYSE: MED)

1-Day Change
2.75%
5-Day Change
4.37%
1-Month Change
13.50%
3-Month Change
-5.46%
6-Month Change
12.32%
Year-to-Date (YTD) Change
11.80%
1-Year Change
-12.01%
3-Year Change
-86.01%
5-Year Change
-94.74%
All-Time (Max) Change
117.09%

Contact Information

https://medifastinc.com
410 581 8042
1501 S. Clinton Street, Baltimore, MD, 21224

Company Facts

3,800 Employees
IPO DateDec 30, 1993
CountryUS
Actively Trading

Frequently Asked Questions